HIGHLIGHTS
- What: Data sources Frontiers in Immunology Data extraction and assessment of risk of bias Data pertinent to the study objectives were extracted by a primary investigator and subsequently verified for accuracy by an independent secondary reviewer.
- Who: . and collaborators from the United States King Saud University, Saudi Arabia have published the Article: Ef fi cacy and safety of adding immune checkpoint inhibitors to rst-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials, in the Journal: (JOURNAL)
- How: Given the need in the treatment landscape . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.